$1.48
-0.07-4.52%
At close: -
$1.70
0.2214.86%
After Hours: Mar 18, 5:27 PM EDT
Comments
Loading...
SAB Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SABS | Benzinga
SAB Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 11
EPS Estimate
$-1.210
Quarterly Revenue Estimate
$120.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics | -$0.54 | $0.00 | — | — | $944.58K | $333.33K | — | — | 05/19/2025 | Get Alert |
| SABS | SAB Biotherapeutics | -$3.84 | -$1.21 | — | — | $305.01K | $120.00K | — | — | 04/11/2025 | Get Alert |
| SABS | SAB Biotherapeutics | -$0.97 | -$1.07 | -$1.12 | -4.67% | $1.27M | $170.00K | $0.00 | -100.00% | 11/06/2024 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.40 | -$1.03 | -$0.79 | 23.30% | $85.52K | — | $263.14K | — | 08/08/2024 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.50 | -$0.46 | -$0.54 | -17.39% | $581.10K | — | $944.58K | — | 05/20/2024 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.80 | -$0.62 | -$3.84 | -519.35% | $2.16M | — | $305.01K | — | 03/29/2024 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.60 | -$1.20 | -$1.00 | 16.67% | $3.59M | $20.00K | $1.27M | 6235.00% | 11/13/2023 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.10 | — | -$1.40 | — | $6.35M | — | $85.52K | — | 08/21/2023 | Get Alert |
| SABS | SAB Biotherapeutics | $0.20 | -$0.80 | -$1.50 | -87.50% | $11.80M | $2.36M | $581.10K | -75.38% | 05/16/2023 | Get Alert |
| SABS | SAB Biotherapeutics | — | -$0.30 | -$1.80 | -500.00% | — | $6.50M | $2.16M | -66.75% | 04/14/2023 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.60 | -$1.60 | -$1.60 | 0.00% | $14.68M | $6.85M | $3.59M | -47.59% | 11/15/2022 | Get Alert |
| SABS | SAB Biotherapeutics | -$1.10 | — | -$1.10 | — | $18.21M | — | $6.35M | — | 08/10/2022 | Get Alert |
| SABS | SAB Biotherapeutics | $0.50 | — | $0.20 | — | $16.93M | — | $11.80M | — | 05/12/2022 | Get Alert |
SAB Biotherapeutics (SABS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $-1.12 | $-1.07 | -4.67 % |
| Q2 | 2024-08-08 | $-0.79 | $-1.03 | 23.3 % |
| Q1 | 2024-05-20 | $-0.54 | $-0.46 | -17.4 % |
| Q4 | 2024-03-29 | $-3.84 | $-0.62 | -519.4 % |
SAB Biotherapeutics (SABS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $0 | $170.00K | -100.0 % |
| Q3 | 2023-11-13 | $1.27M | $20.00K | 6235.0 % |
| Q1 | 2023-05-16 | $581.10K | $2.36M | -75.4 % |
| Q4 | 2023-04-14 | $2.16M | $6.50M | -66.8 % |
FAQ
When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?
SAB Biotherapeutics (SABS) is scheduled to report earnings on May 19, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for SAB Biotherapeutics (NASDAQ:SABS)?
The Actual EPS was $-1.12, which missed the estimate of $-1.07.
What were SAB Biotherapeutics’s (NASDAQ:SABS) revenues?
The Actual Revenue was $0K, which missed the estimate of $170K.
Browse earnings estimates, EPS, and revenue on all stocks.